NASDAQ: SNTI - Senti Biosciences, Inc.

六个月盈利: +0.5128%
股息率: 0.00%
部门: Healthcare

促销时间表 Senti Biosciences, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications.

更多详情
The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells. In addition, the company develops Tumor-Associated Antigen and Protective Antigen Paired Discovery Platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2022-06-09
ISIN US81726A1007
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.sentibio.com
Цена ао 0.412
每日价格变化: -5.31% (4.14)
每周价格变化: -1.26% (3.97)
每月价格变化: +83.18% (2.14)
3个月内价格变化: +73.45% (2.26)
六个月内的价格变化: +0.5128% (3.9)
每年价格变化: +493.94% (0.66)
3年内价格变化: -60.32% (9.88)
5年内价格变化: 0% (3.92)
10年价格变化: 0% (3.92)
年初以来价格变化: +83.18% (2.14)
所有参数

低估

姓名 意义 年级
P/S 9.51 1
P/BV 0.3641 10
P/E 0 0
EV/EBITDA -0.4243 0
全部的: 5

效率

姓名 意义 年级
ROA, % -59.47 0
ROE, % -106.19 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.6122 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 2912.94 10
盈利能力 Ebitda, % 186.62 10
盈利能力 EPS, % 1244.77 10
全部的: 10
更多详情

机构 体积 分享, %
NEA Management Company, LLC 4426151 9.67
8vc Gp I, LLC 2537558 5.55
ARK Investment Management, LLC 1969860 4.31
Vanguard Group Inc 707052 1.55
Intel Corporation 595665 1.3
Triatomic Management Lp 310533 0.68
Geode Capital Management, LLC 238406 0.52
Omega Fund Management, Llc 195792 0.43
Bridgeway Capital Management, Inc. 145000 0.32
Artal Group S.A. 55555 0.12



导师 职称 支付 出生年份
Dr. Timothy K. Lu M.D., Ph.D. Co-Founder, CEO & Director 868.57k 1981 (44 年)
Dr. James J. Collins Ph.D. Scientific Co-Founder, Chairperson of Scientific Advisory Board & Independent Director 58.5k 1966 (59 年)
Dr. Kanya Rajangam M.D., Ph.D. President, Head of Research & Development and Chief Medical Officer 689.99k 1974 (51 年)
Dr. Wilson Wong Ph.D. Scientific Co-Founder & Member of Scientific Advisory Board N/A
Ms. Yvonne Li M.B.A. Interim CFO, Treasurer & Principal Accounting Officer 1960 (65 年)
Mr. Thomas P. Chung Vice President of Strategic Finance & Corporate Development
Ms. Dee Olomajeye Dragon Vice President of People Strategy & Culture

地址: United States, South San Francisco. CA, 2 Corporate Drive - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.sentibio.com